NCT02845882 2026-03-18LBL-2016 for Children or Adolescents in ChinaChildren's Cancer Group, ChinaPhase 3 Active not recruiting150 enrolled
NCT07199855 2025-09-30Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic LeukemiaZhejiang UniversityPhase 2 Active not recruiting24 enrolled